ArticleBone marrow transplantation2021

The association of mobilising regimen on immune reconstitution and survival in myeloma patients treated with bortezomib, cyclophosphamide and dexamethasone induction followed by a melphalan autograft.

Matthew J Rees et al.PubMed ↗Publisher ↗

No numbers read from the abstract.